Shorter antibiotics for heart device wire infections
Part of Infections clinical trials.
This trial is testing whether a shorter course of antibiotics (instead of the usual longer course) is safe and effective for people who have had an infection on the wires of their pacemaker or defibrillator, after the device has been completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed infection on the wires (leads) of your pacemaker or defibrillator (CIED).
- Your entire heart device and leads have been completely removed.
- You are not pregnant or nursing, and if you could become pregnant, you are using effective birth control.
- You do not have an infection on a heart valve or another infection elsewhere that needs long-term antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing a heart device (like a pacemaker) versus using antibiotics and other medical care to treat an infection. It may help doctors decide the best way to handle infections related to these devices.
This trial tests if a new, faster approach to replacing an infected pacemaker or defibrillator is safe. If you have a heart device infection and meet recovery milestones, you might be able to get a new device sooner than usual.
This trial studies whether people with an implanted heart device infection should take antibiotics for life or stop antibiotics and monitor closely. It is for situations where doctors think removing the device is not a safe or suitable option.
This study is testing an approach to improve how clinicians care for people with suspected infections around an implanted heart device (like a pacemaker or defibrillator). It may help ensure the infection is recognized and treated appropriately, especially when device removal (extraction) might be needed.
This trial compares taking antibiotics by mouth versus receiving antibiotics through a vein (outpatient IV) for an infection of the heart valve. It’s designed to see whether the oral option can work as well and safely, especially after initial treatment and surgery if needed.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
Hear when a new Cardiac Devices Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.